Cellebrite DI Ltd. CLBT
10.79
(0.58)
(5.10%)
as of 25 Sep
- Market cap
- $2.9B
- P/E
- 45.0×
Follow CLBT
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 18.66 | 7.06 | 0.00 | 0.00 | 56.34 |
P/S ratio |
— | 0.00 | 0.00 | 4.69 | 3.05 | 4.93 | 11.50 | 9.16 |
P/FCF ratio |
— | 0.00 | 0.00 | 37.33 | 60.36 | 18.02 | 38.84 | 402.64 |
P/Operating CF |
— | 34.65 | (1,635.43) | 38.77 | 23.10 | 36.57 | 69.95 | 50.18 |
P/B ratio |
— | 238.37 | 1.49 | 0.00 | 11.18 | 46.86 | 13.73 | 9.00 |
Price to Tangible BV |
— | 238.37 | 1.53 | 0.00 | 23.08 | 0.00 | 15.59 | 15.38 |
EV/Sales |
— | 0.00 | 0.00 | 3.95 | 2.37 | 4.00 | 10.39 | 8.24 |
EV/EBITDA |
— | 0.00 | 0.00 | 46.73 | 65.09 | 30.85 | 64.50 | 51.59 |
EV/Operating CF |
— | 0.00 | 0.00 | 27.00 | 31.21 | 12.74 | 31.53 | 22.58 |
EV/FCF |
— | 0.00 | 0.00 | 31.46 | 46.94 | 14.62 | 35.08 | 362.24 |
Quick Ratio |
— | — | 1.94 | 1.34 | 1.26 | 1.50 | 1.79 | 1.47 |
Current Ratio |
— | — | 2.03 | 1.46 | 1.42 | 1.66 | 1.92 | 1.56 |
Net Debt/EBITDA |
— | 0.00 | (16.08) | (8.72) | (18.61) | (7.19) | (6.92) | (5.75) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 1.07 | 0.70 | 0.73 | 0.69 | 0.66 | 0.58 |
Operating CF/Net income |
— | (1.61) | (7.12) | 0.51 | 0.18 | (1.26) | (0.47) | 2.22 |
Capex/Depreciation |
— | (1.52) | (1.05) | (1.16) | (1.03) | (0.89) | (1.73) | (16.92) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | (4.08%) | (1,476.12%) | 44,830.50% | (150.08%) | (152.88%) | 19.10% | |
| — | 0.00% | (5.13%) | 20.00% | 31.25% | (17.33%) | (46.26%) | 9.61% | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 87.90% |
Return on Tangible Assets |
— | 0.00% | (5.16%) | 68.12% | 110.15% | (44.04%) | (97.90%) | 34.29% |
Average Days of Receivables |
— | 0.00 | 124.20 | 100.06 | 106.22 | 86.75 | 74.93 | 80.55 |
Research and Development Expense of Revenue |
— | 27.10% | 27.90% | 26.62% | 29.79% | 25.96% | 24.53% | 23.94% |
Selling, General and Administrative Expense of Revenue |
— | 52.94% | 47.94% | 50.49% | 51.08% | 47.45% | 45.68% | 46.28% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.04 | 0.11 | 0.09 | 0.07 | 0.06 | 0.21 |
Share Based Compensation of Revenue |
— | 7.42% | 3.73% | 2.63% | 5.06% | 5.84% | 7.62% | 9.44% |
Graham Net Nets |
— | (0.50) | (0.09) | (0.12) | (0.04) | (0.05) | 0.05 | 0.03 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 2.41 | 0.00 | 0.00 | 3.80 |
Earnings Yield |
— | 0.00% | 0.00% | 5.36% | 14.16% | (5.10%) | (6.31%) | 1.77% |
Free Cash Flow Yield |
— | 0.00% | 0.00% | 2.68% | 1.66% | 5.55% | 2.57% | 0.25% |
Revenue per Share |
— | 1.41 | 1.58 | 1.71 | 1.48 | 1.71 | 1.92 | 1.97 |
Operating CF per Share |
— | 0.13 | 0.54 | 0.25 | 0.11 | 0.54 | 0.63 | 0.72 |
Capex per Share |
— | (0.05) | (0.05) | (0.06) | (0.05) | (0.04) | (0.06) | (0.66) |
Free Cash Flow per Share |
— | 0.08 | 0.49 | 0.19 | 0.06 | 0.50 | 0.57 | 0.05 |
Cash per Share |
— | 0.00 | 1.96 | 1.26 | 1.01 | 1.59 | 2.14 | 1.81 |
Shareholders Equity per Share |
— | 0.00 | 0.52 | (0.51) | 0.40 | 0.18 | 1.60 | 2.00 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.52 | (0.51) | 0.40 | 0.18 | 1.60 | 2.00 |
Free Cash Flow |
— | 9.92 | 60.33 | 27.94 | 11.49 | 94.14 | 118.81 | 12.86 |
Working Capital |
— | — | 164.89 | 86.64 | 88.15 | 168.26 | 272.09 | 206.19 |
Capital Expenditures |
— | (6.21) | (6.18) | (8.11) | (9.08) | (7.92) | (13.36) | (160.68) |
Net Current Asset Value |
— | 0.00 | 23.69 | (139.92) | (33.50) | (76.59) | 213.05 | 121.32 |
EV/EBIT |
— | 0.00 | 0.00 | 70.42 | 615.09 | 39.12 | 73.23 | 58.96 |
Capex to Sales |
— | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.34 |
Net Profit Margin |
— | (5.84%) | (4.79%) | 28.60% | 42.90% | (24.95%) | (70.54%) | 16.47% |
Price to Operating Income |
— | 0.00 | 0.00 | 83.55 | 790.97 | 48.23 | 81.09 | 65.53 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.00 | 0.37 | 0.42 | 0.51 | 0.56 | 0.45 | 0.43 |
Cash ROIC |
— | 0.00% | 16.44% | 17.83% | 1.29% | 25.56% | 14.71% | 16.43% |
Accounts Receivable Turnover |
— | 0.00 | 2.91 | 3.68 | 3.70 | 4.17 | 5.03 | 5.08 |
Accounts Payable Turnover |
— | 0.00 | 0.65 | 0.72 | 0.89 | 1.03 | 0.98 | 0.93 |
Inventory Turnover |
— | 0.00 | 6.73 | 7.56 | 6.08 | 5.29 | 6.63 | 9.09 |
Average Days of Payables |
— | 0.00 | 518.79 | 545.39 | 360.10 | 364.29 | 433.89 | 427.67 |
Days of Inventory on Hand |
— | 0.00 | 45.81 | 55.84 | 73.19 | 68.16 | 52.13 | 36.92 |
Average Receivables |
— | — | 66.91 | 66.91 | 73.13 | 78.02 | 79.81 | 93.67 |
Average Payables |
— | — | 58.71 | 58.71 | 56.83 | 51.60 | 63.77 | 81.24 |
Average Inventory |
— | — | 5.63 | 5.63 | 8.34 | 10.06 | 9.44 | 8.27 |
Average Assets |
— | 0.00 | 182.19 | 352.09 | 371.54 | 468.09 | 611.73 | 814.71 |
Average Common Equity |
— | — | 229.20 | (4.77) | 0.26 | 54.04 | 185.12 | 410.17 |
Columns are period end dates